Streetbeat News

Products Services

HPCO

Hempacco's stock is trading higher following the announcement of an exclusive Master Distribution Agreement with CBDAY Global, which will sell Hempacco's hemp and CBD products exclusively in India and Thailand.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 10:08 pm

BTCUSD

Brett Harrison, former president of FTX US, predicts Bitcoin could reach $50,000 to $55,000 by Q1 2024 if a spot Bitcoin ETF is approved. He doesn't foresee six-figure prices until late 2024 or early 2025. Harrison's views are based on the significant inflows seen when a Bitcoin Futures ETF was listed, expecting even higher records for a spot Bitcoin ETF. He expressed frustration with the lack of crypto regulations and believes the potential of a Bitcoin ETF approval hasn't been fully priced in. Harrison is currently a co-founder at Architect.xyz, a DeFi platform.

Portfolio Pulse from Khyathi Dalal

December 06, 2023 | 9:41 pm

DOV

Dover Fueling Solutions (DFS), a part of Dover (NYSE:DOV), has successfully installed the LIQAL Boil-off Gas Treatment Unit (BTU) system at LC3 Trasporti's refueling station in Italy. This system allows the station to offer both LNG and 100% Bio-LNG, improving refueling efficiency and reducing environmental impact. The LIQAL BTU system ensures stable tank pressure and prevents methane emissions, supporting LC3's decarbonization efforts in heavy transport.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:40 pm

DTM

DT Midstream, Inc. (NYSE:DTM) has announced the early mechanical completion of its Phase 2 LEAP expansion, which will be available for service on January 1, 2024. This expansion increases LEAP's capacity to 1.7 Bcf/d, enhancing connectivity between Haynesville production and Gulf Coast markets, including several LNG terminals.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:39 pm

NOTV

Inotiv has announced plans to take direct control of its transportation operations, aiming to improve efficiencies, its outgoing supply chain, and service continuity for clients. The company will partner with Vanguard Supply Chain Solutions for the in-house integration.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:36 pm

TTWO

The release of Take-Two Interactive Software Inc's (NASDAQ:TTWO) GTA 6 trailer has sparked fan theories about the game's plot, particularly due to the inclusion of Tom Petty's song 'Love Is A Long Road.' Fans are connecting the song's lyrics to the game's narrative and speculating about in-game locations. The trailer features a modern-day Vice City and introduces characters Lucia and Jason. Despite no official PC version announcement, there is high anticipation for the game's release on PlayStation 5 and Xbox Series X | S in 2025.

Portfolio Pulse from Franca Quarneti

December 06, 2023 | 9:34 pm

EGRX

Eagle Pharmaceuticals, Inc. will present an abstract on a post-hoc analysis of Amisulpride for PONV at the 77th PGA in NYC. The analysis shows that Barhemsys, an FDA-approved antiemetic, significantly reduces nausea in PONV patients. A unique J-code for Barhemsys will be effective from January 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:29 pm

ANIX

Anixa Biosciences, Inc. (NASDAQ:ANIX) is set to release new data from its ongoing Phase 1 breast cancer vaccine trial after a presentation at the 2023 SABCS. A conference call is scheduled for today at 6:30 p.m. ET to discuss the findings. The vaccine was first administered in 2021 to a Triple Negative Breast Cancer survivor. Key Opinion Leaders in oncology, including the inventor of Herceptin, Dr. H. Michael Shepard, and Dr. Brian Leyland-Jones, are advisors to Anixa and will participate in the call.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:19 pm

HPCO

Hempacco has entered into an exclusive master distribution agreement with CBDAY Global, granting CBDAY the exclusive rights to sell Hempacco's line of CBD products in India and Thailand.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:13 pm

AZN

ILMN

GRAIL, LLC, in collaboration with Samsung Medical Centre and AstraZeneca (NASDAQ:AZN), presented validation data on a novel prognostic test for early-stage lung cancer at the North America Conference on Lung Cancer. The test, which uses a plasma-based targeted methylation assay, showed potential in identifying high-risk patients for recurrence of Lung Adenocarcinoma (LUAD). GRAIL, a subsidiary of Illumina, Inc. (NASDAQ:ILMN), aims to detect cancer early and is developing technology for multi-cancer early detection.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:12 pm